Early research (Phase 1)WithdrawnNCT04388761
What this trial is testing
Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI)
Who this might be right for
Ischemia Reperfusion Injury
Tambi Jarmi